Alluvium

Alluvium Unveils AI-Powered Platform to Transform Health System Access and Capacity

Rebranding and New Platform Reflect Alluvium’s Commitment to Unified Data Management How can health systems navigate the complex challenges of capacity management and revenue optimization? Alluvium, formerly known as BlockIt, is addressing this critical issue with the launch of its…

Read MoreAlluvium Unveils AI-Powered Platform to Transform Health System Access and Capacity
Alcanza Clinical

Alcanza Clinical Research Wins 2025 HCPEA Impact Award for Inclusive Research

Alcanza Clinical Research Recognized for Advancing Community-Based Clinical Trials How can healthcare organizations ensure that clinical research truly reflects the communities it serves? The Healthcare Private Equity Association (HCPEA) has recognized Alcanza Clinical Research (Alcanza) with its 2025 HCPEA Impact…

Read MoreAlcanza Clinical Research Wins 2025 HCPEA Impact Award for Inclusive Research
IntraBio Inc.

IntraBio Inc. Secures Orphan Medicinal Product Designation for CACNA1A Disorders

Positive Opinion Paves Way for Phase III Trial of Acetylleucine in Rare Neurological Conditions Why are rare neurological disorders often overlooked in drug development? IntraBio Inc., an Austin, Texas-based global biopharmaceutical company, is addressing this gap by advancing a potential…

Read MoreIntraBio Inc. Secures Orphan Medicinal Product Designation for CACNA1A Disorders
Five Discovery

Five Discovery Launches to Repair Dysfunctional Brain Circuits in Neurodegenerative Disease

Biotech Firm to Present at Psychedelic Therapeutics Conference in New Orleans Why are current treatments for neurodegenerative diseases often limited to symptom management? Five Discovery, a biotechnology company, is addressing this gap by developing small-molecule therapeutics to repair dysfunctional brain…

Read MoreFive Discovery Launches to Repair Dysfunctional Brain Circuits in Neurodegenerative Disease
MiraDx

MiraDx Launches PROSTOX™ Standard to Personalize Prostate Cancer Radiation Therapy

Expanding Access to Personalized Radiation Therapy for Prostate Cancer Patients Why do more than 20% of prostate cancer patients experience persistent urinary side effects after radiation therapy? MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment,…

Read MoreMiraDx Launches PROSTOX™ Standard to Personalize Prostate Cancer Radiation Therapy
Altais Health

Altais Health Solutions and Autonomize AI Streamline Healthcare with AI-Driven Prior Authorization

Strategic Partnership Reduces Administrative Burden and Enhances Operational Efficiency In the rapidly evolving healthcare landscape, how can technology reduce administrative friction while maintaining clinical oversight? Altais Health Solutions and Autonomize AI have demonstrated a compelling answer through their strategic partnership.…

Read MoreAltais Health Solutions and Autonomize AI Streamline Healthcare with AI-Driven Prior Authorization